Skip to search formSkip to main contentSkip to account menu

VIPhyb

Known as: VIP Hybrid 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Peptides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Abstract 1205: Targeting vasoactive intestinal peptide signaling to enhance pancreatic cancer responsiveness to immunotherapy
Background: Pancreatic ductal adenocarcinoma (PDAC) is projected to become the second leading cause of cancer related death in… 
2015
2015
Blocking VIP Signaling during Allogeneic Bone Marrow Transplantation Separates the Graft Versus Leukemia from Graft Versus Host Disease Activity of Donor CD8 T-Cells
Background: Separating graft versus leukemia (GvL) from graft versus host disease (GvHD) is a critical issue in allogeneic bone… 
2015
2015
Administration of a vasoactive intestinal peptide antagonist significantly enhances the autologous anti-leukemia T cell response in a murine model of AML
Products secreted from nerve terminals can have profound effects on the phenotype and functioning of T cells. One such product… 
2013
2013
Pharmacological Inhibition Of Semi-Direct Alloantigen Presentation and The Generation Of Cross-Dressed Antigen Presenting Cells: A Novel approach To Limit Graft Versus Host Disease Following…
Background Graft versus host disease (GVHD) following allogeneic hematopoietic stem cell transplant (allo-HSCT) is caused by CD4… 
2012
2012
Blockade of VIP-Signaling Enhanced Anti-Leukemic Activity in Murine Allogeneic BMT without Significantly Increased GvHD.
Abstract 3001 Background and Objective: Vasoactive intestinal peptide (VIP) has potent immune-suppressive activity and can… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)